What is the recommended treatment for Lyme disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Lyme Disease

For early Lyme disease with erythema migrans, treat adults with doxycycline 100 mg twice daily for 10-14 days, and children under 8 years with amoxicillin 50 mg/kg/day divided three times daily for 14 days. 1, 2

Early Localized Disease (Erythema Migrans)

First-Line Treatment for Adults

  • Doxycycline 100 mg twice daily for 14 days (range 10-21 days) is the preferred treatment for adults with early localized or early disseminated Lyme disease 1, 2
  • Doxycycline has the critical advantage of also treating potential coinfection with Anaplasma phagocytophilum (human granulocytic anaplasmosis), which may occur simultaneously with Lyme disease 1, 2
  • A 10-day course of doxycycline is sufficient based on randomized controlled trial evidence 1, 3

Alternative Oral Regimens for Adults

  • Amoxicillin 500 mg three times daily for 14-21 days is equally effective and preferred for pregnant or lactating women 1, 2
  • Cefuroxime axetil 500 mg twice daily for 14-21 days is another effective alternative 1, 2

Pediatric Treatment

  • Children under 8 years: Amoxicillin 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) for 14 days 1, 4
  • Children ≥8 years: Doxycycline 4 mg/kg/day in 2 divided doses (maximum 100 mg per dose) for 14 days 1, 4
  • Cefuroxime axetil 30 mg/kg/day in 2 divided doses (maximum 500 mg per dose) for 14 days is an alternative for children under 8 years 1, 4

Macrolides: Last Resort Only

  • Macrolides (azithromycin, clarithromycin, erythromycin) are NOT recommended as first-line therapy because they are less effective 1
  • Reserve macrolides only for patients who cannot tolerate doxycycline, amoxicillin, AND cefuroxime axetil 1, 5
  • If macrolides must be used: azithromycin 500 mg daily for 7-10 days, clarithromycin 500 mg twice daily for 14-21 days, or erythromycin 500 mg four times daily for 14-21 days 1
  • Patients on macrolides require close monitoring to ensure clinical resolution 1, 4

Early Neurologic Disease

Meningitis or Radiculopathy

  • Intravenous ceftriaxone 2 g once daily for 14 days (range 10-28 days) is the preferred treatment for adults with Lyme meningitis or radiculopathy 1, 2, 5
  • Pediatric dosing: ceftriaxone 50-75 mg/kg/day (maximum 2 g) as a single daily IV dose 1, 2, 4
  • Alternative parenteral options: cefotaxime 2 g IV every 8 hours or penicillin G 18-24 million units/day IV divided every 4 hours 1, 5

Oral Doxycycline for Neurologic Disease

  • Recent high-quality evidence demonstrates oral doxycycline 200 mg daily for 14-28 days is equally effective as IV ceftriaxone for Lyme neuroborreliosis 6, 7
  • A 2021 randomized equivalence trial showed oral doxycycline 100 mg twice daily for 4 weeks was equivalent to IV ceftriaxone 2 g daily for 3 weeks 6
  • A 2008 double-blind randomized trial confirmed oral doxycycline 200 mg daily for 14 days was non-inferior to IV ceftriaxone 2 g daily for 14 days 7
  • This represents a major shift from older guidelines, offering a more convenient and cost-effective option for many patients with neurologic Lyme disease 6, 7

Facial Nerve Palsy (Cranial Nerve VII)

  • Isolated facial nerve palsy without meningitis can be treated with oral antibiotics (same regimens as erythema migrans) 1, 8
  • A prospective study showed oral doxycycline 200-400 mg daily for 9-17 days resulted in 90% complete recovery within 6 months 8
  • The 2020 guidelines make no recommendation on corticosteroids for facial nerve palsy 1

Lyme Carditis

Treatment Approach

  • Outpatients: Oral antibiotics (same regimens as erythema migrans) for 14-21 days 1, 2
  • Hospitalized patients: Start with IV ceftriaxone 2 g daily until clinical improvement, then switch to oral antibiotics to complete 14-21 days total 1, 2

Hospitalization Criteria

  • Admit patients with symptomatic bradycardia, PR interval >300 milliseconds, second- or third-degree AV block, or clinical manifestations of myopericarditis 1, 2
  • Continuous ECG monitoring is required for hospitalized patients 1, 2
  • For symptomatic bradycardia requiring intervention, use temporary pacing rather than permanent pacemaker implantation 1, 2

Late Disease (Lyme Arthritis)

Initial Treatment

  • Oral antibiotics (same regimens as erythema migrans) for 28 days 1, 2
  • Use doxycycline, amoxicillin, or cefuroxime axetil at standard doses 1, 2

Recurrent or Persistent Arthritis

  • For recurrent arthritis after initial oral course: Either repeat 28-day oral course OR switch to IV ceftriaxone 2 g daily for 14-28 days 1, 2, 5
  • Consider other causes of joint swelling before additional antibiotic treatment 5

Tick Bite Prophylaxis

When to Offer Prophylaxis

Single-dose doxycycline 200 mg (pediatric: 4 mg/kg for children ≥8 years) is recommended ONLY when ALL of the following criteria are met: 1, 2

  • Attached tick reliably identified as adult or nymphal Ixodes scapularis 1, 2
  • Estimated attachment ≥36 hours (based on degree of engorgement or known time of attachment) 1, 2
  • Prophylaxis can be started within 72 hours of tick removal 1, 2
  • Doxycycline is not contraindicated 1, 2
  • Local Lyme disease risk is ≥20% 1

When NOT to Use Prophylaxis

  • Do NOT substitute amoxicillin for doxycycline prophylaxis - there is no evidence for an effective short-course regimen 1
  • Prophylaxis is generally not necessary for Ixodes pacificus (West Coast) tick bites 1

Critical Pitfalls to Avoid

Ineffective Antibiotics

The following antibiotics are INEFFECTIVE for Lyme disease and should NEVER be used: 1, 2, 5, 4

  • First-generation cephalosporins (e.g., cephalexin) 1, 2, 4
  • Fluoroquinolones 2, 5, 4
  • Carbapenems 2, 5
  • Vancomycin 2, 5
  • Metronidazole 2, 5
  • Tinidazole 2, 5
  • Trimethoprim-sulfamethoxazole 2
  • Benzathine penicillin G 2

Inappropriate Treatment Strategies

The following treatment approaches are NOT recommended and may cause harm: 2, 5

  • Long-term antibiotic therapy beyond recommended durations 2, 5, 4
  • Combination antimicrobial therapy 2, 5
  • Pulsed-dosing regimens 2, 5

Post-Treatment Monitoring

  • Do NOT use serologic testing to monitor treatment response - antibodies remain positive for months to years after successful treatment 5
  • Antibody levels do not correlate with clinical response 5
  • Clinical improvement is the most reliable indicator of treatment success 5
  • Persistent positive serology does NOT indicate ongoing infection or treatment failure 5

Special Populations

Pregnancy

  • Treat pregnant patients identically to non-pregnant patients with the same disease manifestation, but avoid doxycycline 1, 2
  • Use amoxicillin or cefuroxime axetil for early disease 1
  • Use IV ceftriaxone for neurologic or cardiac involvement 1, 2

Coinfections

  • Consider coinfection with Anaplasma phagocytophilum or Babesia microti in patients with fever after tick bite or persistent symptoms despite appropriate therapy 1, 5
  • Doxycycline treats both Lyme disease and anaplasmosis but NOT babesiosis 1
  • Babesiosis requires atovaquone plus azithromycin for 7-10 days (mild disease) or clindamycin plus quinine (severe disease) 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lyme Disease Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Children with Borrelia burgdorferi (Lyme Disease)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Chronic Lyme Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral Doxycycline Compared to Intravenous Ceftriaxone in the Treatment of Lyme Neuroborreliosis: A Multicenter, Equivalence, Randomized, Open-label Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Research

Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.